Publicacións en colaboración con investigadores/as de University of Massachusetts Medical School (2)

2018

  1. Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: A pooled analysis of the PALACE 1-3 studies

    RMD Open, Vol. 4, Núm. 1

2016

  1. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: A phase III, randomised, controlled trial (PALACE 3)

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 6, pp. 1065-1073